In a major leap toward self-reliance in defense technology, India is set to develop its very own fifth-generation fighter jet—the Advanced Medium Combat Aircraft (AMCA) . In a historic move, Defence Minister Rajnath Singh has approved an innovative execution model for the indigenous stealth fighter programme. This model brings together Hindustan Aeronautics Limited (HAL) and private industry players in a competitive framework, marking a significant shift in how India approaches military aviation manufacturing. This bold initiative comes at a critical time, as China has already fielded two fifth-generation fighters , and reports indicate it will supply 40 J-35 stealth jets to Pakistan . Against this backdrop, fast-tracking the AMCA has become an urgent national security imperative. AMCA: India’s Indigenous Stealth Fighter Dream The AMCA project , spearheaded by the Aeronautical Development Agency (ADA) under the Defence Research and Development Organisation (DRDO) , received its l...
CAR T-Cell Therapy: A Revolutionary Cancer Treatment Introduction CAR T-cell therapy is an advanced form of immunotherapy that utilizes a patient's own immune cells (T-cells) to fight cancer. It has shown remarkable success in treating blood cancers like leukemia and lymphoma. Recently, the Central Drugs Standard Control Organisation (CDSCO) approved India's second "living drug," Qartemi, a CAR T-cell therapy for blood cancer treatment. What is CAR T-Cell Therapy? CAR (Chimeric Antigen Receptor) T-cell therapy is a type of personalized medicine that modifies a patient's T-cells in the laboratory to help them recognize and attack cancer cells. This therapy harnesses the power of the immune system to specifically target cancer cells while sparing healthy ones. How Does CAR T-Cell Therapy Work? The process involves several key steps: T-Cell Collection : A patient's T-cells (a type of white blood cell) are extracted from their blood using a process called leukaph...